Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Eton Pharmaceuticals, Inc. (NASDAQ: ETON)
ETON Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
42.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
48.50%
ETON Stock Analysis
ETON
PE Ratio:
ETON
PEG Ratio:
ETON
Forward EPS Growth (12 month):
148.80%
ETON
PS Ratio:
8.7
ETON
PSG Ratio:
0.2
ETON
Forward Revenue Growth (12 month):
51.70%
ETON Articles
No data was found